EWALD STEPHEN P 4

What Happened

• Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, exercised stock options to acquire 3,500 shares at $138.87 per share, costing $486,045 (transaction date 2026-04-24). The same filing also shows a simultaneous disposition of 3,500 derivative shares at $0, and two awards of restricted stock units (RSUs) totaling 15,000 shares (10,000 and 5,000) granted at $0.

Key Details

• Transaction date: April 24, 2026; Form 4 filed April 28, 2026 (reporting period: 2026-04-24).
• Option exercise: 3,500 shares acquired at $138.87 each — total cash paid $486,045 (code M = option exercise/conversion).
• Simultaneous disposition: 3,500 derivative shares reported disposed at $0 (code M) — recorded in the same filing.
• Awards/grants: 10,000 RSUs and 5,000 RSUs granted at $0 (code A). Each RSU equals one contingent right to receive one share (see footnote F3).
• Vesting notes: the exercised option vested in full on Feb 15, 2026 (F1). The RSUs vest in full on the fifth anniversary of the grant subject to continued employment (F4). Another option referenced vests on the fifth anniversary of its grant (F2).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: filing date is April 28 for transactions dated April 24 (check full filing for official timeliness status).

Context

• The filing records both an option exercise (cash paid to acquire shares) and a same-day disposition of an equal number of derivative shares at $0; this pattern is commonly associated with a cashless exercise or share withholding to cover exercise costs or taxes, though the filing does not state the exact mechanism.
• The RSU grants are non-cash awards that vest in the future (subject to continued employment) and do not represent immediately tradable shares until vested and settled.